AKBANasdaq CM

Akebia Therapeutics, Inc.

0.96+6.37%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelElevated

Tier and alert level are a summary. Unlock AKBA to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+12.49%, upReturn · 1w
−25.12%, downReturn · 1m
−6.95%, downReturn · 3m
−68.37%, downReturn · 1y
−71.13%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 43.

RSI (14)42.70, caution readingLower-neutral
MACD / signal-0.08 / -0.09, favorable readingAbove signal line
SMA 501.14, caution readingPrice below
SMA 2001.33, caution readingPrice below
EMA 200.99, caution readingPrice below
ADX (14)29.97Trending
+DI / −DI24.36 / 31.72, caution reading−DI leading
ATR (14)0.08, flagged reading8.5% of price — elevated daily swings
Stochastic %K73.67Mid-range
Bollinger bands (20)0.62 – 1.41Inside bands
ROC (10)10.54, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking AKBA reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock AKBA: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get AKBA + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock AKBA